Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 42 studies with search of: | "Neurofibroma" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas
|
||||
2 | Suspended |
Study of PEG-Intron for Plexiform Neurofibromas
|
||||
3 | Recruiting |
Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1
|
||||
4 | Recruiting |
Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
|
||||
5 | Recruiting |
Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1
|
||||
6 | Active, not recruiting |
Study of Plexiform Neurofibromas in Neurofibromatosis Type 1
|
||||
7 | Recruiting |
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
|
||||
8 | Recruiting |
Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
|
||||
9 | Completed |
Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
|
||||
10 | Active, not recruiting |
Pirfenidone in Treating Young Patients With Neurofibromatosis Type I and Recurrent or Progressive Plexiform Neurofibromas
|
||||
11 | Recruiting |
Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas
|
||||
12 | Suspended |
Tipifarnib in Preventing Cancer in Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
|
||||
13 | Recruiting |
Sirolimus in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed By Surgery
|
||||
14 | Active, not recruiting |
Natural History Study of Plexiform Neurofibromas in Patients With Neurofibromatosis Type 1
|
||||
15 | Recruiting |
PEG-Interferon Alfa-2b in Treating Young Patients With Unresectable Plexiform Neurofibromas Associated With Neurofibromatosis Type 1
|
||||
16 | Recruiting |
Sorafenib in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed by Surgery
|
||||
17 | Recruiting |
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||||
18 | Active, not recruiting |
PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma
|
||||
19 | Recruiting |
Medical Treatment of "High-Risk" Neurofibromas
|
||||
20 | Recruiting |
A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |